Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. KEQU
KEQU logo

KEQU Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
37.020
Open
36.011
VWAP
36.49
Vol
4.82K
Mkt Cap
104.63M
Low
36.011
Amount
175.90K
EV/EBITDA(TTM)
6.29
Total Shares
2.87M
EV
144.67M
EV/OCF(TTM)
7.76
P/S(TTM)
0.39
Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.
Show More

Events Timeline

(ET)
2026-06-23
17:30:00
Kewaunee Reports Q4 Revenue of $71.4M
select
2026-03-11 (ET)
2026-03-11
16:10:00
Kewaunee Reports Q3 Revenue of $69.4M, Successfully Acquires Nu Aire
select
2025-09-10 (ET)
2025-09-10
16:11:48
Kewaunee Scientific announces Q1 EPS of $1.04, up from 74 cents last year
select
2025-09-10
16:11:16
Kewaunee Scientific announces Q1 EPS of $1.04, up from 74 cents last year
select
2025-03-12 (ET)
2025-03-12
17:11:13
Kewaunee Scientific announces amendment to share repurchase program
select
2024-12-11 (ET)
2024-12-11
15:07:52
Kewaunee Scientific reports Q3 EPS $1.01 vs. 93c last year
select
2024-09-11 (ET)
2024-09-11
16:50:12
Kewaunee Scientific reports Q1 EPS 74c vs. 86c last year
select

News

NASDAQ.COM
9.5
06-24NASDAQ.COM
Kewaunee Scientific Reports Decline in Q4 Profit
  • Profit Decline: Kewaunee Scientific Corporation reported a fourth-quarter net profit of $3.39 million, or $1.13 per share, which represents a significant drop from last year's $4.85 million and $1.63 per share, indicating a weakening in the company's profitability.
  • Adjusted Earnings: Excluding special items, the company reported adjusted earnings of $3.40 million, or $1.14 per share, which, while slightly higher than GAAP figures, still reflects overall profitability challenges.
  • Revenue Drop: The company's fourth-quarter revenue fell to $71.40 million, a 7.5% decrease from $77.15 million last year, suggesting potential impacts on market demand that warrant attention for future sales strategies.
  • Market Reaction: The dual decline in profit and revenue has led to a cautious market outlook for Kewaunee Scientific, which may affect its stock performance and investor confidence moving forward.
PRnewswire
9.5
06-23PRnewswire
Kewaunee Scientific Reports Strong FY 2026 Results Amid Challenges
  • Significant Sales Growth: Kewaunee Scientific reported sales of $281.99 million for FY 2026, a 17.3% increase, demonstrating the company's ability to achieve robust growth post-Nu Aire integration despite market challenges, enhancing its competitive position.
  • Profitability Fluctuations: Net earnings for FY 2026 were $9.62 million, down 15.7% from the previous year, reflecting pressures from high costs and project delivery timeline volatility, indicating a need for improved cost controls to maintain profitability.
  • Strong International Performance: International sales reached $67.11 million, a 9.9% increase, showcasing the resilience of the international team in navigating geopolitical uncertainties through effective project execution and management, supporting future growth potential.
  • Balance Sheet Improvement: The company successfully reduced long-term debt by approximately $20 million, improving its debt-to-equity ratio from 0.99 to 0.61, indicating enhanced financial health and laying the groundwork for future acquisitions and expansion.
Newsfilter
9.5
06-23Newsfilter
Kewaunee Reports Strong Fiscal Year 2026 Results with Revenue Growth
  • Significant Sales Growth: Kewaunee achieved sales of $281.99 million in fiscal year 2026, representing a 17.3% increase compared to the previous year, indicating strong market demand post-Nu Aire integration and enhancing its position in the laboratory products sector.
  • Profitability Fluctuations: Despite the sales growth, net earnings for fiscal year 2026 were $9.62 million, down 15.5% from $11.41 million the previous year, reflecting profitability pressures amid high costs and market volatility, necessitating further cost optimization to maintain margins.
  • Strong International Performance: International sales reached $67.11 million, a 9.9% increase, demonstrating the company's resilience in the global market and robust project backlog despite heightened geopolitical uncertainties, bolstering confidence in future growth prospects.
  • Improved Balance Sheet: The company successfully reduced long-term debt by approximately $20 million in fiscal year 2026, improving its debt-to-equity ratio from 0.99 to 0.61, indicating significant progress in financial health and laying a solid foundation for future expansion and acquisitions.
seekingalpha
9.5
06-23seekingalpha
Kewaunee Scientific Reports Fiscal Year 2026 Earnings
  • Earnings Highlights: Kewaunee Scientific reported a Q4 GAAP EPS of $1.13, with revenue of $71.4 million reflecting a 7.5% year-over-year decline, indicating resilience amid market challenges.
  • Annual Sales Growth: The company achieved $281.99 million in sales for fiscal year 2026, representing a 17.3% increase from $240.47 million in the previous year, showcasing positive performance in product demand and market share.
  • Profitability Changes: Pre-tax earnings for the fiscal year were $13.73 million, down from $14.79 million the prior year, while net earnings decreased from $11.41 million to $9.62 million, reflecting the impact of cost pressures on profitability.
  • Decline in EPS: Diluted earnings per share fell to $3.22 from $3.83 in the previous fiscal year, indicating challenges in profitability that may affect investor confidence.
PRnewswire
9.5
06-10PRnewswire
Kewaunee Scientific to Release Q4 and FY 2026 Financial Results on June 23
  • Earnings Release Plan: Kewaunee Scientific Corporation plans to release its fourth quarter and fiscal year 2026 financial results on June 23, 2026, after market close, which is expected to provide investors with crucial performance data and future outlook.
  • Company Background: Founded in 1906, Kewaunee is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, including steel and wood casework, fume hoods, and biological safety cabinets, showcasing its strong industry presence.
  • Acquisition Details: The recently acquired subsidiary, Nu Aire, specializes in manufacturing biological safety cabinets and ultralow freezers, which complements Kewaunee's product portfolio and enhances its competitive edge in the market.
  • Global Operations: Kewaunee operates multiple sales and manufacturing facilities across the U.S., India, and other countries, demonstrating its extensive international footprint and capability to serve global customers.
seekingalpha
9.5
03-11seekingalpha
Kewaunee Scientific Q3 Financial Highlights
  • Earnings Performance: Kewaunee Scientific reported a Q3 GAAP EPS of $0.23, indicating stability in profitability despite facing market challenges.
  • Revenue Growth: The company achieved revenues of $69.4 million in Q3, reflecting a year-over-year increase of 3.3%, showcasing sustained demand in the laboratory equipment market and an expanding customer base.
  • Market Performance Analysis: Although the revenue growth rate is modest, the stable profitability and slight increase suggest that the company maintains a solid competitive position in the industry, potentially attracting more investor interest.
  • Future Outlook: Kewaunee Scientific's financial performance lays a foundation for future growth, and management may leverage this positive trend to drive new product development and market expansion strategies.

Valuation Metrics

The current forward P/E ratio for Kewaunee Scientific Corp (KEQU.O) is 7.72, compared to its 5-year average forward P/E of 12.69. For a more detailed relative valuation and DCF analysis to assess Kewaunee Scientific Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
12.69
Current PE
7.72
Overvalued PE
19.65
Undervalued PE
5.74

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
9.08
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
13.42
Undervalued EV/EBITDA
4.74

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.52
Current PS
0.00
Overvalued PS
0.80
Undervalued PS
0.24

Financials

AI Analysis
Annual
Quarterly

Whales Holding KEQU

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Kewaunee Scientific Corp (KEQU) stock price today?

The current price of KEQU is 36.45 USD — it has decreased -1.09

What is Kewaunee Scientific Corp (KEQU)'s business?

Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.

What is the price predicton of KEQU Stock?

Wall Street analysts forecast KEQU stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for KEQU is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Kewaunee Scientific Corp (KEQU)'s revenue for the last quarter?

Kewaunee Scientific Corp revenue for the last quarter amounts to 71.40M USD, decreased -7.45

What is Kewaunee Scientific Corp (KEQU)'s earnings per share (EPS) for the last quarter?

Kewaunee Scientific Corp. EPS for the last quarter amounts to 1.13 USD, decreased -30.67

How many employees does Kewaunee Scientific Corp (KEQU). have?

Kewaunee Scientific Corp (KEQU) has 1239 emplpoyees as of July 08 2026.

What is Kewaunee Scientific Corp (KEQU) market cap?

Today KEQU has the market capitalization of 104.63M USD.